跳转至内容
Merck
CN

MAB2241

ANTI-TAU (MAPT) Antibody

mouse monoclonal, Tau 12

别名:

G protein beta1/gamma2 subunit-interacting factor 1, Neurofibrillary tangle protein, Paired helical filament-tau, microtubule-associated protein tau, microtubule-associated protein tau, isoform 4

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Clone:
Tau 12, monoclonal
Species reactivity:
human
Application:
WB
Citations:
8
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

抗Tau抗体,克隆Tau 12, clone Tau 12, from mouse

biological source

mouse

Quality Level

antibody form

purified antibody

clone

Tau 12, monoclonal

species reactivity

human

technique(s)

western blot: suitable

isotype

IgG1κ

UniProt accession no.

shipped in

wet ice

target post-translational modification

unmodified

General description

50-68kda
微管相关蛋白或MAP与微管结构的微管蛋白亚基结合并调节其功能稳定性。在细胞中,MAP与单体和多聚微管蛋白结合。MAP与多聚微管蛋白的结合进一步稳定了更高阶微管蛋白结构的形成。MAP与微管结构的结合是通过微管亲和力调节激酶(MARK)的磷酸化介导的。磷酸化释放与微管结合的MAP,使结构不稳定,促使其分解。主要有两种 MAP类型,I,II。II型MAP包括MAP2,MAP4和tau,存在于神经组织中。脑组织中存在六种tau亚型,它们的结合结构域数量不同。三个亚型具有三个结合结构域,其他三个亚型具有四个结合结构域。结合结构域位于蛋白的羧基末端,并带正电(使其与带负电的微管结合)。具有四个结合结构域的亚型比具有三个结合结构域的亚型在稳定微管方面更好。

Immunogen

KLH偶联合成线性肽。
表位:N末端

Application

抗Tau抗体,克隆Tau 12是针对 Tau的抗体,用于 WB。
研究子类别
神经退行性疾病
研究类别
神经科学

Biochem/physiol Actions

与其他物种的反应性尚未确定。
目录号MAB2241识别Tau的N端区域。

Physical form

在含 0.05%NaN3 的 0.1M Tris-甘氨酸(pH7.4)150mM NaCl 中纯化。
形式:纯化
纯化的蛋白G

Preparation Note

自收到之日起,在 2-8ºC 条件下可稳定保存1年

Analysis Note

对照
人脑组织裂解物。
蛋白质印迹:

Other Notes

替代品:MAB10417
浓度:请参考批次特异性浓缩物的分析证书。

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。


Still not finding the right product?

Explore all of our products under 抗Tau抗体,克隆Tau 12


存储类别

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容

Alzheimer’s Disease: Amyloid Cascade and Beyond Product Focus


Hiroki Takeuchi et al.
NPJ vaccines, 5, 28-28 (2020-03-29)
Pathological aggregates of tau proteins accumulate in the brains of neurodegenerative tauopathies including Alzheimer's disease and frontotemporal lobar degeneration (FTLD-tau). Although immunotherapies of these disorders against tau are emerging, it is unknown whether nasal delivery, which offers many benefits over
Carmen Romero-Molina et al.
Frontiers in cellular neuroscience, 12, 421-421 (2018-11-30)
Microglial cells are crucial players in the pathological process of neurodegenerative diseases, such as Alzheimer's disease (AD). Microglial response in AD has been principally studied in relation to amyloid-beta pathology but, comparatively, little is known about inflammatory processes associated to
Jessica L Binder et al.
PloS one, 15(3), e0230026-e0230026 (2020-03-26)
Pathological accumulation of microtubule associated protein tau in neurons is a major neuropathological hallmark of Alzheimer's disease (AD) and related tauopathies. Several attempts have been made to promote clearance of pathological tau (p-Tau) from neurons. Transcription factor EB (TFEB) has



全球贸易项目编号

货号GTIN
MAB224104053252726934